Home / Private raises / Zai Lab Ltd

Zai Lab Ltd

Biotechnology · Cambridge, Massachusetts · $250M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-09D (new)$250M$250M25506(b)EquityOct 27SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Sold through (placement agents)

Broker-dealerSolicited in
LEERINK PARTNERS LLCAll States

Sales commissions $7.5M in the latest filing.

Issuer

IndustryBiotechnology
LocatedCambridge, Massachusetts
EntityOther
IncorporatedCayman Islands
SEC CIK1704292

People named in the latest filing

NameRole
SAMANTHA (YING) DU, Ph.D.Executive Officer, Director
JOHN DAVID DIEKMAN, Ph.D.Director
RICHARD BRIAN GAYNOR, M.D.Director
NISA BERNICE WING-YU LEUNGDirector
WILLIAM DAVID LISDirector
SCOTT WILLIAM MORRISONDirector
LEON OLIVER MOULDER, JR.Director
MICHEL PERICLES VOUNATSOSDirector
PETER KARL WIRTH, J.D.Director
YAJING CHEN, Ph.D.Executive Officer
RAFAEL G. AMADO, M.D.Executive Officer
F. TY EDMONDSON, J.D.Executive Officer

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?